Skip to content

Dier & Dorp: what changed

BE 0446.683.614NACE 75.000, Veterinary servicesOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
-€65,861
2024 · -€68,921+€3,060
Equity
-€109,782
2024 · -€43,921-€65,861
Cash
€54,814
2024 · €25,492+€29,322
Balance sheet total
€240,448
2024 · €212,837+€27,611

Largest movements

2024 to 2025
Assets
  • Cash +€29,322

    up €29,322 (+115%), from €25,492 to €54,814

    mainly Debts after one year (+€67,029) and Depreciation (+€26,910)

  • Tangible fixed assets -€18,139

    down €18,139 (-21.1%), from €86,022 to €67,883

    of which Plant, machinery and equipment: -€9,273

  • Receivables within one year +€9,260

    up €9,260 (+29.4%), from €31,539 to €40,799

    of which Trade receivables: +€13,350

  • Stocks and contracts +€7,028

    up €7,028 (+20.1%), from €34,965 to €41,993

Equity and liabilities
  • Debts after one year +€67,029

    up €67,029 (+40.7%), from €164,585 to €231,614

  • Profit (loss) carried forward -€65,861

    down €65,861 (-95.6%), from -€68,921 to -€134,782

  • Trade debts +€20,624

    up €20,624 (+31.2%), from €66,025 to €86,649

  • Accrued charges and deferred income +€2,604

    up €2,604 (+80.1%), from €3,249 to €5,853

Income statement
  • Gross operating margin -€17,425

    down €17,425 (-19.0%), from €91,583 to €74,158

  • Write-downs -€12,557

    no longer reported in 2025; in 2024 it stood at €12,557

  • Financial charges +€6,989

    up €6,989 (+328%), from €2,132 to €9,121

  • Staff costs +€6,574

    up €6,574 (+7.0%), from €93,376 to €99,950

  • Depreciation +€5,216

    up €5,216 (+24.0%), from €21,694 to €26,910

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2024 -€68,921
Gross operating margin -€17,425
Staff costs -€6,574
Depreciation -€5,216
Write-downs +€12,557
Other operating charges +€4,291
Other operating items +€21,955
Financial income +€460
Financial charges -€6,989
Result 2025 -€65,861
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€30,033
Investment -€8,771
Financing +€68,126
Cash 2024 €25,492
Net result for the year -€65,861
Depreciation +€26,910
Stocks and contracts -€7,028
Receivables within one year -€9,260
Deferred charges and accrued income -€140
Trade debts +€20,624
Tax, wage and social debts +€2,119
Accrued charges and deferred income +€2,604
Investment in fixed assets (net) -€8,771
Debts after one year +€67,029
Current portion of long-term debt +€1,097
Cash 2025 €54,814
brings cash intakes cash out
Every line side by side 49 lines
Line Code 2024 2025 Change %
Total assets 20/58 €212,837 €240,448 +€27,611 +13.0%
Fixed assets 21/28 €110,196 €92,057 -€18,139 -16.5%
Tangible fixed assets 22/27 €86,022 €67,883 -€18,139 -21.1%
Plant, machinery and equipment 23 €34,144 €24,871 -€9,273 -27.2%
Furniture and vehicles 24 €5,447 €4,172 -€1,275 -23.4%
Leasing and similar rights 25 €39,225 €31,650 -€7,576 -19.3%
Other tangible fixed assets 26 €7,206 €7,190 -€15 -0.2%
Financial fixed assets 28 €24,174 €24,174 = 0.0%
Current assets 29/58 €102,641 €148,391 +€45,750 +44.6%
Stocks and contracts in progress 3 €34,965 €41,993 +€7,028 +20.1%
Stocks 30/36 €34,965 €41,993 +€7,028 +20.1%
Amounts receivable within one year 40/41 €31,539 €40,799 +€9,260 +29.4%
Trade receivables 40 €7,995 €21,345 +€13,350 +167%
Other amounts receivable 41 €23,545 €19,455 -€4,090 -17.4%
Cash at bank and in hand 54/58 €25,492 €54,814 +€29,322 +115%
Deferred charges and accrued income 490/1 €10,644 €10,784 +€140 +1.3%
Total equity and liabilities 10/49 €212,837 €240,448 +€27,611 +13.0%
Equity 10/15 -€43,921 -€109,782 -€65,861 -150%
Contributions 10/11 €12,400 €12,400 = 0.0%
Reserves 13 €12,600 €12,600 = 0.0%
Tax-exempt reserves 132 €3,672 €3,672 = 0.0%
Distributable reserves 133 €8,928 €8,928 = 0.0%
Profit (loss) carried forward 14 -€68,921 -€134,782 -€65,861 -95.6%
Amounts payable 17/49 €256,757 €350,229 +€93,472 +36.4%
Amounts payable after more than one year 17 €164,585 €231,614 +€67,029 +40.7%
Financial debts 170/4 €164,585 €231,614 +€67,029 +40.7%
Amounts payable within one year 42/48 €88,923 €112,763 +€23,840 +26.8%
Current portion of amounts payable after more than one year 42 €10,246 €11,343 +€1,097 +10.7%
Trade debts 44 €66,025 €86,649 +€20,624 +31.2%
Suppliers 440/4 €66,025 €86,649 +€20,624 +31.2%
Taxes, remuneration and social security 45 €12,651 €14,771 +€2,119 +16.8%
Taxes 450/3 - €2,944 +€2,944
Remuneration and social security 454/9 €12,651 €11,827 -€825 -6.5%
Accrued charges and deferred income 492/3 €3,249 €5,853 +€2,604 +80.1%
Non-recurring operating income 76A €20,000 €20,000 = 0.0%
Remuneration, social security and pensions 62 €93,376 €99,950 +€6,574 +7.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €21,694 €26,910 +€5,216 +24.0%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €12,557 - -€12,557
Other operating charges 640/8 €8,910 €4,619 -€4,291 -48.2%
Non-recurring operating charges 66A €21,955 - -€21,955
Gross operating margin 9900 €91,583 €74,158 -€17,425 -19.0%
Operating profit (loss) 9901 -€66,909 -€57,321 +€9,589 +14.3%
Financial income 75/76B €120 €581 +€460 +382%
Recurring financial income 75 €120 €581 +€460 +382%
Financial charges 65/66B €2,132 €9,121 +€6,989 +328%
Recurring financial charges 65 €2,132 €9,121 +€6,989 +328%
Profit (loss) for the period before taxes 9903 -€68,921 -€65,861 +€3,060 +4.4%
Profit (loss) for the period 9904 -€68,921 -€65,861 +€3,060 +4.4%
Profit (loss) for the period to be appropriated 9905 -€68,921 -€65,861 +€3,060 +4.4%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

The filed figures and these assumptions give no positive value. The adjusted equity and the average result are both zero or negative.

Part of the calculation comes out below zero. A shareholding is never worth less than zero, so the floor is zero.

Adjusted equity -€109,782

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
-€109,782
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
-€109,782

Capitalised earnings

net result for the year (9904)
2025
-€65,861
excluding non-recurring income and charges
-€85,861
2024
-€68,921
excluding non-recurring income and charges
-€66,966
2023
€32,592
2022
€10,169
2021
€5,249
excluding non-recurring income and charges
€4,949
Average result, excluding non-recurring income and charges
-€40,078
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 20 November 2026 via checked.be.